Targeting the placenta with obstetric nanomedicine

Lynda Harris (below) is a biomedical researcher at The University of Manchester (UK) and has been a pioneer in the use of nanotechnology for obstetric medical research, specifically in directing drugs to the placenta. Harris’ research focuses on developing and repurposing drugs to treat pregnancy complications such as preeclampsia, which currently have no medical treatments available, and uses nanomedical technology to localize their release in the placenta. After a PhD in vascular remodeling and heart disease, Harris moved to the University of Manchester to look at vascular remodeling of the uterus during pregnancy, after which she became interested in placental...